Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move; Episode 512 - 2020 Round Up
Delta, Kelowna, BC, January 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/010421-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/01041Round-Up-2020.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be taking a quick look back at 2020 and the year’s main
highlights.
Sales Growth:
While COVID-19 has had a significantly
negative impact on most industries this year, the cannabis sector has seen
substantial sales growth month over month as the year has progressed. This can
be attributed to many factors related to COVID measures as well as to the
success and growth of the industry itself.
One
of the first contributing factors that helped sales growth this year was the
very different place the entire industry was at the start of 2020 when compared
to years previous. Supply issues were a massive factor contributing to lower
sales in 2018 and 2019 in Canada and in the US, multi-state operators were
still in the process and gaining the footing and building out their
infrastructure. Looking at the start of 2020 we saw in Canada that many of the
large scale producers who struggled in the first two years finally hit their
stride as far as product supply levels and quality and consistency of their
products. We also began to see the development of a premium bud segment in the
industry through partnerships with smaller niche cultivators and the Cannabis
2.0 products that had been in the wing for months finally started hitting
retail shelves. The retail development
within Canada was also in a much more stable and built out position starting
in 2020 than in other years with private retail stores in BC and Ontario, the
two most populous provinces, seeing massive growth.
Image courtesy of: MJBIZ Daily
With
the industry being in a much better starting position entering 2020, the next
big factor to impact sales was obviously COVID-19 and lockdowns.
In
Canada with so many people stuck at home due to lockdown procedures and mahy
receiving government aid checks from being out of the work, we saw a massive
spike in Cannabis usage and sales as many who were on the fence socially about
this substance in years previous changed their perception.
This
was also massively aided by Cannabis businesses being deemed essential in both
the US and Canada as well as other parts of the world where legal cannabis
operations are in place. This change from Illegal to essential brought many new
consumers to the market and has helped remove some of the long standing stigma
surrounding the industry.
These
contributing factors which aided to sales gave many companies in the industry
the much needed revenue boost they had been waiting for and allowed many
companies the time and financial resources to begin expansion and innovation.
Industry Innovation:
Increased sales and
revenues in many ways helped stabilize what was previously a very unstable
industry, which allowed many to use the time to innovate and expand.
We
saw a plethora of Cannabis 2.0 products that had been stuck in development hell
for months finally begin hitting shelves and as more products hit retail stores
we saw competitors continue to innovate and adapt their products to consumers
needs as the year progressed.
Not
only did many companies innovate with regards to their products but we also saw
many retailers build out their online capabilities and begin offering delivery
and cubside services, where regulators allowed, which again helped increase
their customer share and overall sales.
Now
most of the US and Canadian cannabis retail sector offers online sales,
delivery or curbside pickup as well as touchless transactions and interactive
menus, all features that had been slowly developing over the last two years but
suddenly saw a massive jump in 2020 due to the necessity for innovation COVID
created.
This
also translated to the underserved medical community who saw massive growth in
Telemedicine usage globally and in medical cannabis countries, there were
serious adjustments to the overall medical industry which now allows for easier
access to cannabis medication, delivery and curbside pick up options,
telemedicine prescription and information access as well as a massive growth in
product selection and inventory.
Continued
Legalization and Social Acceptance:
While I had already mentioned the
massive social change created from Cannabis businesses being deemed essential
this year, there was also another huge shift in the US, as well as globally
towards cannabis reform policy and general drug reform policy.
This
year saw many new states in the US vote for cannabis reform such as New Jersey,
Montanna, Arizona and South Dakota, which all voted in favor of cannabis
reform. We also saw states like Oregan set new drug policy precedent in the US
by voting in favor of decriminalizing virtually all drugs and legalizing
medicinal psilocybin.
On
a global scale we saw more countries in South America extend or improve their
cannabis drug policies in favour of import and export opportunities and
increased medical availability. One of the largest holdouts as well as probably
one of the largest potential markets, Mexico looks to have some sort of medical
cannabis program in place in 2021, though regulatory progress has been slow so
far. Even in South East Asia we have seen a growing leniency towards CBD
products with some countries beginning the process of implementing a medical
cannabis program, again most likely in 2021 or 2022.
In
the EU, while we haven’t seen any major changes to the legal landscape, 2020
did help continue to build out the EU infrastructure for the medical and CBD
industry and we have seen massive growth when it comes to import and export
markets.
What’s Next?
Looking ahead at 2021 and beyond
there's a lot of hype and expectation surrounding the cannabis industry once
again. One of the best things to come out of 2020 has been increased investor
confidence and interest in this industry that saw a large investment slump
since legalization in Canada in 2018. Many of the the industries largest
companies are now trading back up at their regular prices and many smaller
companies have had their best trading year to date.
This increase in investor and consumer
confidence in the industry should help push some of the last needed
advancements in regulation and industry reform to boost the cannabis industry
into the same social and societal acceptance of alcohol, if not allowing it
surpass alcohol due to alcohol's many negative health impacts.
Looking at the US in 2021 we can
definitely expect more speculation and hype surrounding the idea of either Safe
Banking Access or decriminalization of cannabis, at least one of these outcomes
seems likely this year. We have seen many companies in both the US and Canada
preparing for the merging of markets and with the implementation of at least
Safe Banking Access a floodgate of investor capital becomes available to US
based cannabis companies.
Looking at Canada, there is
expectation of regulatory reform surrounding delivery access in some provinces,
private retail expansion as well a hopeful reevaluation of dosage and packaging
restrictions, all of which would greatly benefit overall industry.
Looking globally and at the industry
as a whole, South American expansion of both medical and recreational markets
seems inevitable as does expansion of the EU recreational market. There is a
lot of excitement surrounding South East Asian markets establishing medical
markets though this looks to be further out than 2021, though CBD products are
very much in play. Finally we have seen a lot of infrastructure build out in
Israel and parts of Africa, both of which could have massive impacts on the
global pricing of Cannabis and CBD products as well as the import and export
markets.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade
these stocks and other ideas on our site using our list of top stock trading apps including
Robinhood, Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and
stock directory
